speb/financial-data huggingface dataset:
Financial scorecard for YRB.TO (Basic Materials — Gold, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.03546099290780142
Market cap: 23766918 (USD: 17098502.158273384)
P/E ratio: 324.8057849842288
P/B ratio: 0.9689477477851061
Debt to equity: 0.0004
Current ratio: 35.71
Interest coverage ratio: -194.5402576489533
Return on net tangible assets (%): -0.780835350756077
Buffett classification: The Gruesome
Rule of 40 score: -6720.039424460432
Altman Z-score: 50.61155019400609 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.020065952153159202
Total shareholder yield (%): 0.020065952153159202 (Low Return)
Momentum (%): 1m -16.075650118203303, 3m -30.597771023302933, 6m -30.091185410334354, 12m 20.567375886524832, composite -5.675661534217125 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 7, recommendation: Neutral
Net income growth 1y (%): -55.77399693597
Revenue deceleration: no
Accrual ratio: 0.026417269790496793
FCF conversion rate: -9.365128400997552
Beneish M-score: -1.5955722468647842 (Possible Manipulation)
ROE (%): 0.25768322357330326
Net margin (%): 712.144
Asset turnover: 0.00035788658984852855
Equity multiplier (leverage): 1.0110506196522508
ROE archetype: Low Return
P/E z-score: 2.5871156666725326
Treasury beta 1y: -0.0007811827577283561 (R-squared: 8.227215391876582e-06)
Insider 90-day net shares: 560000 (net value USD: 25512.00)
ROIC (%): -2.92798156565553 (pretax: -3.706305779310797)
Incremental ROIC 3y (%): -2.536373740134592 (pretax: -3.210599671056444)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 25.77903682719547, P/B 9.206798866855523, ROIC 21.10481586402266, revenue growth 1y , 6m momentum 41.359773371104815
Sector percentiles: P/E 36.78511937812326, 6m momentum 54.108828428650746
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.12169904430081026
Base cash flow: -735375.912408759
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for YRL.AX (Basic Materials — Gold, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.11805555555555557
Market cap: 63135580 (USD: 41265084.96732026)
Debt to equity: 0.0091
Current ratio: 14.78
Buffett classification: The Gruesome
Analyst consensus upside (%): 767
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -18.485449735449734, 3m -21.296296296296287, 6m -33.70726495726496, 12m 4.861111111111115, composite -8.787529207576533 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.0009692426424124969 (R-squared: 1.2365775349981872e-05)
Insider 90-day net shares: 143445 (net value USD: 22606.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 47.1671388101983
Sector percentiles: P/E , 6m momentum 58.0788450860633
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for Z (Communication Services — Internet Content & Information, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 30.77
Market cap: 7037943808 (USD: 7037943808)
P/E ratio: 165.52
P/B ratio: 1.6918497909936479
Debt to equity: 0.0973
Current ratio: 2.29
Interest coverage ratio: 9
Return on net tangible assets (%): 7.957292506043514
Buffett classification: The Gruesome
Analyst consensus upside (%): 34.920251329144506
Rule of 40 score: 18.850101072928005
Altman Z-score: 5.049523729005153 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 3.5094560343146814, earnings yield % 0.5395728999918656, rank 1972
Dividend yield (%): 0
Buyback yield (%): 8.894643337283092
Debt paydown yield (%): 0.3978434719551543
Total shareholder yield (%): 9.292486809238246 (Moderate Return)
Momentum (%): 1m 0.7531106745252142, 3m -32.23959480290684, 6m -54.75000000000001, 12m -61.72885572139304, composite -49.66817339201373 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 8, short score 3, recommendation: Neutral
Revenue growth 1y (%): 18.394648829431446
Net income growth 1y (%): 475
Revenue deceleration: no
Accrual ratio: -0.020163138117496104
FCF conversion rate: 3.391304347826087
Beneish M-score: -2.5891301799193234 (Likely Safe)
ROE (%): 0.9900990099009901
Net margin (%): 6.497175141242938
Asset turnover: 0.12977728897442947
Equity multiplier (leverage): 1.1742359018510546
ROE archetype: Low Return
P/E z-score: 1.3774504484883972
FCF z-score: 4.165943955140241
Treasury beta 1y: 0.004274850386849967 (R-squared: 0.0016384235552248693)
Insider 90-day net shares: -55216 (net value USD: -2152750.00)
ROIC (%): -0.7276322293623332 (pretax: -0.7909045971329708)
Incremental ROIC 3y (%): 2.3673276676109536 (pretax: 3.493862134088763)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 53.30578512396694, P/B 31.40495867768595, ROIC 48.34710743801653, revenue growth 1y 9.50413223140496, 6m momentum 78.51239669421489
Sector percentiles: P/E 51.42392188771359, 6m momentum 79.0886899918633
Industry median P/E: 1.5943877551020407; industry median ROIC: 5.940137180901089
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.14992423003991714
Base cash flow: 162000000
DCF price per share: base 16.235095475550118, conservative 13.047505110908125, aggressive 20.837341419024852
Financial scorecard for 096.DE (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 200
Market cap: 9009564672 (USD: 9009564672)
P/E ratio: 146.53451717255146
P/B ratio: 6.2736072508923275
Debt to equity: 0.12380000000000001
Current ratio: 1.61
Interest coverage ratio: 118.51836734693877
Return on net tangible assets (%): 3.977266818859001
Buffett classification: The Good
Rule of 40 score: 7.767047052717669
Altman Z-score: 3.2308491132878014 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 2.2933428530584616, earnings yield % 0.38355149516591497, rank 2367
Dividend yield (%): 0
Buyback yield (%): 2.294017608223901
Debt paydown yield (%): 0.16664512156353828
Total shareholder yield (%): 2.4606627297874395 (Low Return)
Momentum (%): 1m 11.041009463722391, 3m -8.021390374331556, 6m -38.47267462902642, 12m , composite -23.247032501678987 (Strong Downtrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 7, short score 6, recommendation: Neutral
Revenue growth 1y (%): 23.364984589791593
Revenue deceleration: no
Accrual ratio: -0.030190505282225638
FCF conversion rate: 4.562787983043559
Beneish M-score: -2.8449050093763537 (Likely Safe)
ROE (%): 1.602451769913247
Net margin (%): 3.695140154030386
Asset turnover: 0.22932398887004454
Equity multiplier (leverage): 1.8910567596942573
ROE archetype: Low Return
P/E z-score: 2.1140019673012773
FCF z-score: 3.2063077038573873
Treasury beta 1y: 0.28866673668203985 (R-squared: 0.018100981887379405)
Insider 90-day net shares: -13267 (net value USD: -3164142.00)
ROIC (%): 1.2076174829106208 (pretax: 1.8271162295619883)
Incremental ROIC 3y (%): 37.176455820324456 (pretax: 47.8394648269395)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 55.39083557951483, P/B 59.299191374663074, ROIC 47.03504043126684, revenue growth 1y 15.902964959568733, 6m momentum 75.06738544474393
Sector percentiles: P/E 53.486820153486825, 6m momentum 71.60493827160494
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.11257942741195562
Base cash flow: 129041000
DCF price per share: base 99.60411408992402, conservative 70.27620985325562, aggressive 150.52061792568992
Financial scorecard for 1188.HK (Consumer Cyclical — Auto Parts, Hong Kong)
Report date: 2025-12-31 (annual)
Stock price: 0.0012755102040816328
Market cap: 244234464 (USD: 31392604.627249356)
P/E ratio: 5.5198721921783465
Debt to equity: -0.0005373556445910912
Current ratio: 0.86
Interest coverage ratio: 3852.9999999999995
Return on net tangible assets (%): -34.52665900224279
Buffett classification: The Great
Rule of 40 score: 21.65605095541401
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 40.99609999985154
Total shareholder yield (%): 40.99609999985154 (High Return)
Momentum (%): 1m 0, 3m -0.1275510204081604, 6m -0.510204081632644, 12m 0.12755102040816044, composite -0.1700680272108813 (Flat)
Lynch category: Cyclical (confidence: High)
Screener: long score 5, short score 6, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.1620324492929424 (Likely Safe)
ROE archetype: Standard Business
P/E z-score: 1.6077322353024912
FCF z-score: 3.00851912738458
Treasury beta 1y: 0.0023019444637983905 (R-squared: 0.0050207216156369265)
Insider 90-day net shares: -2000000 (net value USD: -38400.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 56.74931129476584, P/B , ROIC , revenue growth 1y , 6m momentum 39.11845730027548
Sector percentiles: P/E 42.52433936022253, 6m momentum 33.27538247566064
Industry median P/E: 0.2842479295922772; industry median ROIC: 7.591641841963527
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.05
Base cash flow: 4709383.033419023
DCF price per share: base 0.0016469652924582536, conservative 0.0010108218428940548, aggressive 0.0028031168229704544
Financial scorecard for 1878.HK (Energy — Thermal Coal, Hong Kong)
Report date: 2026-03-31 (quarterly)
Stock price: 0.22193877551020408
Market cap: 644755776 (USD: 82239257.14285715)
Debt to equity: -1.201900127153907
Current ratio: 0.26
Interest coverage ratio: 0.33423965818605555
Buffett classification: The Gruesome
Rule of 40 score: -0.9536124823932968
Altman Z-score: -5.041933983042057 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -2.1128691305209495
Total shareholder yield (%): -2.1128691305209495 (Minimal or Negative)
Momentum (%): 1m 0.5780346820809192, 3m -14.814675870348134, 6m -16.37089618456078, 12m -37.77787900874635, composite -23.10701648671891 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 3, short score 5, recommendation: Neutral
Revenue growth 1y (%): 36.78924307235816
Revenue deceleration: no
Accrual ratio: -0.027909267824659446
FCF conversion rate: -0.26406172224987556
Beneish M-score: -3.0070966470572715 (Likely Safe)
Net margin (%): -4.7447819797478825
Asset turnover: 0.4653330522862224
ROE archetype: Standard Business
Treasury beta 1y: -0.11398493710883703 (R-squared: 0.006668785351031842)
Insider 90-day net shares: -50000 (net value USD: 29270.00)
ROIC (%): -63.65113492416721 (pretax: -80.57105686603444)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 72.54901960784314, revenue growth 1y 0, 6m momentum 62.745098039215684
Sector percentiles: P/E , 6m momentum 62.140733399405356
Industry median P/E: 1.6213917999632284; industry median ROIC: 5.423977083364904
Sector median P/E: 11.598358576086895; sector median ROIC: 4.629877910100043
WACC: 0.10276376431578008
Base cash flow: -24848843.187660668
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 1965.HK (Real Estate — Real Estate - Diversified, China)
Report date: 2025-12-31 (annual)
Stock price: 0.016581632653061226
Market cap: 51826732 (USD: 7403818.857142857)
P/E ratio: 0.2570694087403599
Debt to equity: -0.08561778593913948
Current ratio: 0.67
Interest coverage ratio: 766.6785714285714
Return on net tangible assets (%): -16.507531390287813
Buffett classification: The Good
Rule of 40 score: 9.559787475939281
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -1.3060642352655079
Total shareholder yield (%): -1.3060642352655079 (Minimal or Negative)
Momentum (%): 1m 0, 3m -7.261297376093304, 6m -19.164540816326525, 12m -27.685657596371883, composite -18.03716526293057 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 1, short score 4, recommendation: Neutral
Revenue growth 1y (%): 2.949562249672555
Revenue CAGR 3y (%): -4.526416489319029
Net income CAGR 3y (%): -7.9007867950978135
FCF CAGR 3y (%): 7.6303477923423735
Revenue deceleration: no
Revenue growth consistency score: 11.69045780955293
Beneish M-score: -2.5073905292302356 (Likely Safe)
Net margin (%): 2.9556612280444856
Asset turnover: 0.9101280154078942
ROE archetype: Standard Business
P/E z-score: 2.888750968275116
FCF z-score: 3.792388755208933
Treasury beta 1y: 0.13915360418689668 (R-squared: 0.010795204087900603)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 32.432432432432435, P/B , ROIC , revenue growth 1y 25.675675675675674, 6m momentum 75.67567567567568
Sector percentiles: P/E 14.673913043478262, 6m momentum 62.88819875776398
Industry median P/E: 0.1786011340287656; industry median ROIC: 2.960519784941141
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.05
Base cash flow: 4139428.571428572
DCF price per share: base 0.07289563821982038, conservative 0.06131887150006075, aggressive 0.09051859137770085
Financial scorecard for 2126.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 0.21045918367346939
Market cap: 687180416 (USD: 98168630.85714285)
P/B ratio: 1.6975712195393824
Debt to equity: 0.47200000000000003
Current ratio: 1.45
Interest coverage ratio: -21.209550463529826
Return on net tangible assets (%): -132.6850076311979
Buffett classification: The Gruesome
Rule of 40 score: 57.73425392374655
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 20.73486499167772
Total shareholder yield (%): 20.73486499167772 (High Return)
Momentum (%): 1m -1.7857142857142814, 3m -32.73896293211162, 6m -37.818877551020414, 12m -57.85447469804248, composite -42.548677634319034 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.6775596167200875 (Likely Safe)
Equity multiplier (leverage): 1.6438994709662433
ROE archetype: Standard Business
Treasury beta 1y: -0.07676557417690331 (R-squared: 0.001004116562267437)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -60.67492628731952 (pretax: -76.80370416116395)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 19.4043321299639, ROIC 21.209386281588447, revenue growth 1y , 6m momentum 59.115523465703966
Sector percentiles: P/E , 6m momentum 64.07593123209169
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.14534448038332792
Base cash flow: -67809999.99999999
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2137.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 0.12755102040816327
Market cap: 721177088 (USD: 103025298.28571428)
P/B ratio: 0.39099409027782683
Debt to equity: 0.0038
Current ratio: 60.73
Interest coverage ratio: -146.25242223355428
Return on net tangible assets (%): -10.530941420862236
Buffett classification: The Gruesome
Rule of 40 score: -2538.5649019080893
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.23769698275850087
Total shareholder yield (%): -0.23769698275850087 (Minimal or Negative)
Momentum (%): 1m 1.0101010101010224, 3m -29.667289450991657, 6m -34.97398959583833, 12m -50.43190543544151, composite -38.52295514263903 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 7, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: 0.0981528660918327
FCF conversion rate: 2.092299123185281
Beneish M-score: -1.9137188127862952 (Likely Safe)
Equity multiplier (leverage): 1.0183970827228026
ROE archetype: Standard Business
Treasury beta 1y: -0.02087936290676246 (R-squared: 0.00016274469261374602)
Insider 90-day net shares: -75000 (net value USD: -18024.00)
ROIC (%): -57.68249179593327 (pretax: -73.01581239991552)
Incremental ROIC 3y (%): 83.07965523288078 (pretax: 105.16412054795035)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 4.241877256317689, ROIC 20.667870036101082, revenue growth 1y , 6m momentum 55.505415162454874
Sector percentiles: P/E , 6m momentum 61.46131805157593
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.11520311344936181
Base cash flow: -31256857.14285714
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2297.HK (Healthcare — Medical Devices, China)
Report date: 2025-12-31 (annual)
Stock price: 0.026785714285714284
Market cap: 288679936 (USD: 41239990.85714286)
P/B ratio: 0.9509671379632156
Debt to equity: 0.0693
Current ratio: 1.13
Interest coverage ratio: -103.77916666666667
Return on net tangible assets (%): -18.40138187093522
Buffett classification: The Gruesome
Rule of 40 score: -469.5070501636966
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.10087011409823685
Total shareholder yield (%): -0.10087011409823685 (Minimal or Negative)
Momentum (%): 1m -8.695652173913054, 3m -19.333791208791215, 6m -22.619047619047628, 12m -34.29129464285715, composite -23.328720510640164 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -3.2770185744950355 (Likely Safe)
Equity multiplier (leverage): 1.3175249382519334
ROE archetype: Standard Business
Treasury beta 1y: 0.05952109478717694 (R-squared: 0.0004409991422089025)
Insider 90-day net shares: 184000 (net value USD: 4926.00)
ROIC (%): -25.718264756626752 (pretax: -32.55476551471741)
Incremental ROIC 3y (%): 35.04900426182406 (pretax: 44.36582817952411)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 14.540059347181009, ROIC 42.433234421364986, revenue growth 1y , 6m momentum 47.47774480712167
Sector percentiles: P/E , 6m momentum 52.363896848137536
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07812198291840519
Base cash flow: -8552857.142857144
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2495.HK (Technology — Software - Infrastructure, China)
Report date: 2025-12-31 (annual)
Stock price: 4.691326530612245
Market cap: 1306580352 (USD: 186654336)
P/E ratio: 2.1568181685699126
P/B ratio: 1.105691749051234
Debt to equity: 0.515
Current ratio: 1.36
Interest coverage ratio: 9.631280450669914
Return on net tangible assets (%): -19.220102941590085
Buffett classification: The Gruesome
Rule of 40 score: -16.898846612774857
Altman Z-score: 1.2402485518658197 (Distress Zone)
Piotroski F-score: 1 (Weak)
Magic formula: return on capital % 21.811553788638268, earnings yield % 1.8666036041320406, rank 2328
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -23.087033520278773
Total shareholder yield (%): -23.087033520278773 (Minimal or Negative)
Momentum (%): 1m -13.21378008494573, 3m -28.673617990885674, 6m -40.932450462025, 12m -45.763014336809846, composite -35.70371347917397 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 5, short score 9, recommendation: Neutral
Revenue growth 1y (%): 11.543732543356523
Revenue CAGR 3y (%): 24.806510496842815
Revenue deceleration: yes
Revenue growth consistency score: 24.474707343517714
Accrual ratio: 0.16196343802815774
FCF conversion rate: -2.0425195053416823
Beneish M-score: -1.9746023812935751 (Likely Safe)
ROE (%): 8.621455936767507
Net margin (%): 13.925242369410507
Asset turnover: 0.3822793624886197
Equity multiplier (leverage): 1.6195598322319307
ROE archetype: Standard Business
P/E z-score: 1.2293145450510474
Treasury beta 1y: 0.04008220916314919 (R-squared: 0.00038752304778512516)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 8.613087669512906 (pretax: 10.902642619636588)
Incremental ROIC 3y (%): 5.441480364253065 (pretax: 6.887949828168435)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 23.981900452488688, P/B 14.25339366515837, ROIC 32.35294117647059, revenue growth 1y 34.841628959276015, 6m momentum 72.85067873303167
Sector percentiles: P/E 28.695362028695364, 6m momentum 73.2399065732399
Industry median P/E: 5.36821412369575; industry median ROIC: 3.7232145830700096
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.08796064068142478
Base cash flow: -34167714.28571428
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2501.HK (Technology — Information Technology Services, China)
Report date: 2025-12-31 (annual)
Stock price: 0.15306122448979592
Market cap: 600000000 (USD: 85714285.71428572)
P/E ratio: 11.825192802056556
P/B ratio: 1.3026865296209154
Debt to equity: 0.67
Current ratio: 1.55
Interest coverage ratio: 1.4029393370856789
Return on net tangible assets (%): 3.198363705977578
Buffett classification: The Good
Rule of 40 score: 65.35605458896849
Altman Z-score: 2.1152598163814638 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 8.026031920945393, earnings yield % 0.4720673881779448, rank 4665
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.2152739726027393
Total shareholder yield (%): 0.2152739726027393 (Low Return)
Momentum (%): 1m 20, 3m 3.316326530612253, 6m 37.22730471498944, 12m 35.00343957807842, composite 17.68216585355568 (Moderate Uptrend)
Lynch category:  (confidence: Low)
Screener: long score 8, short score 4, recommendation: Neutral
Revenue growth 1y (%): 52.90849866930414
Net income growth 1y (%): 1272.091718904652
Revenue CAGR 3y (%): 18.081870071859818
Net income CAGR 3y (%): -51.3045449459449
Revenue deceleration: no
Revenue growth consistency score: 28.3754896324845
Beneish M-score: -2.5772256849669635 (Likely Safe)
ROE (%): 1.8261061773596752
Net margin (%): 1.4143144410516122
Asset turnover: 0.5502469008025336
Equity multiplier (leverage): 2.346510190743946
ROE archetype: Low Return
P/E z-score: 4.7227158674262295
FCF z-score: 1.9171813496105223
Treasury beta 1y: 0.18258825740832293 (R-squared: 0.011197556110408296)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 4.075860428787549 (pretax: 4.756543348090854)
Incremental ROIC 3y (%): -18.903662526619087 (pretax: -21.44383130229834)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 51.167728237791934, P/B 24.416135881104033, ROIC 60.72186836518046, revenue growth 1y 2.9723991507431, 6m momentum 4.8832271762208075
Sector percentiles: P/E 35.03503503503504, 6m momentum 12.779446112779446
Industry median P/E: 0.21619799348899724; industry median ROIC: 12.533738935242045
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.05
Base cash flow: 1360428.5714285714
DCF price per share: base 0.02754370932427411, conservative 0.010889932875941196, aggressive 0.06429327217190021
Financial scorecard for 2509.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 2.066326530612245
Market cap: 3618581248 (USD: 516940178.28571427)
P/E ratio: 1.5061428548898388
P/B ratio: 5.652543674952969
Debt to equity: 0.8541
Current ratio: 2.22
Interest coverage ratio: -19.711958103313737
Return on net tangible assets (%): 50.481788513304274
Buffett classification: The Gruesome
Analyst consensus upside (%): 1244.188481675393
Rule of 40 score: 324.4930468241893
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0.7514823666051342
Debt paydown yield (%): -2.0476253322299276
Total shareholder yield (%): -1.2961429656247934 (Minimal or Negative)
Momentum (%): 1m 17.47643219724438, 3m -10.164704415914061, 6m -26.202623906705547, 12m -12.320739106453388, composite -20.577236854000613 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 1, short score 2, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.0611501898476766
FCF conversion rate: 1.2473397996501827
Beneish M-score: 7.818623646181632 (Strong Manipulation Signal)
Equity multiplier (leverage): 3.040696028520929
ROE archetype: Standard Business
P/E z-score: 1.728867109856257
FCF z-score: 1.7288671098562562
Treasury beta 1y: -0.12451389773885126 (R-squared: 0.0037058509166695967)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -137.86251325887926 (pretax: -174.50951045427755)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 4.1516245487364625, P/B 48.55595667870036, ROIC 27.79783393501805, revenue growth 1y , 6m momentum 48.82671480144404
Sector percentiles: P/E 13.825214899713467, 6m momentum 55.372492836676216
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.12547637292431674
Base cash flow: 48438285.71428572
DCF price per share: base 0.3690928640186181, conservative 0.34248970482631713, aggressive 0.3992974759781143
Financial scorecard for 2511.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 0.3380102040816326
Market cap: 1348094592 (USD: 192584941.7142857)
P/B ratio: 3.7027095582072724
Debt to equity: 0.3479
Current ratio: 5.42
Interest coverage ratio: -90.97377326565143
Return on net tangible assets (%): -73.5781454084707
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: -1.908744444351595 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -2.2068569227263763
Total shareholder yield (%): -2.2068569227263763 (Minimal or Negative)
Momentum (%): 1m -10.472972972972974, 3m -27.090360937763535, 6m -5.16260461018941, 12m -24.40512529798245, composite -15.938305608063315 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.1196791057335581
FCF conversion rate: 0.7194281799733736
Beneish M-score: -3.4220388765854373 (Likely Safe)
Equity multiplier (leverage): 1.4746429464480788
ROE archetype: Standard Business
Treasury beta 1y: 0.001742457288244838 (R-squared: 5.95649891794091e-07)
Insider 90-day net shares: 0 (net value USD: 0.00)
Incremental ROIC 3y (%): 0.2597074113959344 (pretax: 0.32874355872903005)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 39.25992779783393, ROIC , revenue growth 1y , 6m momentum 31.949458483754512
Sector percentiles: P/E , 6m momentum 35.17191977077364
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -32270428.57142857
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2522.HK (Healthcare — Medical Care Facilities, China)
Report date: 2025-12-31 (annual)
Stock price: 0.6339285714285714
Market cap: 1964766848 (USD: 280680978.28571427)
P/E ratio: 105.52699228791775
P/B ratio: 1.0625121526727146
Debt to equity: 0.3073
Current ratio: 2.79
Interest coverage ratio: 1.7369871615964276
Return on net tangible assets (%): 4.774156878428781
Buffett classification: The Gruesome
Analyst consensus upside (%): 758.5481120584651
Rule of 40 score: 26.327562321256757
Altman Z-score: 1.8689419072573321 (Grey Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 2.6592028747099867, earnings yield % 0.3609622699038909, rank 5420
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -5.439709104647929
Total shareholder yield (%): -5.439709104647929 (Minimal or Negative)
Momentum (%): 1m -3.4951456310679774, 3m -37.248284269459994, 6m -40.282091097308495, 12m -65.68041871921183, composite -47.322610461219334 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 7, short score 4, recommendation: Neutral
Revenue growth 1y (%): 19.714725597782312
Revenue CAGR 3y (%): 3.4366381416667036
Net income CAGR 3y (%): 117.13831634391587
Revenue deceleration: no
Revenue growth consistency score: 22.060485851229252
Accrual ratio: -0.02146961859019142
FCF conversion rate: 15.405016008537887
Beneish M-score: -2.160594113964386 (Likely Safe)
ROE (%): 0.21866822027526434
Net margin (%): 0.4292651640095291
Asset turnover: 0.3472041745409878
Equity multiplier (leverage): 1.4671519199985879
ROE archetype: Low Return
P/E z-score: 2.2051339647300443
FCF z-score: 2.2051339647300425
Treasury beta 1y: 0.10378183522554116 (R-squared: 0.002269026960498295)
Insider 90-day net shares: -130500 (net value USD: -93685.00)
ROIC (%): 1.9651562599923253 (pretax: 2.4875395696105387)
Incremental ROIC 3y (%): 2.111114884046522 (pretax: 1.2396094704032066)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 61.904761904761905, P/B 25.238095238095237, ROIC 57.61904761904761, revenue growth 1y 13.333333333333334, 6m momentum 77.61904761904762
Sector percentiles: P/E 33.166189111747855, 6m momentum 65.68767908309455
Industry median P/E: 1.7425206697700268; industry median ROIC: 5.681103510179656
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: 12551285.714285713
DCF price per share: base 0.3002855033893094, conservative 0.2239573213588905, aggressive 0.4205588181455693
Financial scorecard for 2550.HK (Communication Services — Advertising Agencies, China)
Report date: 2025-12-31 (annual)
Stock price: 0.2729591836734694
Market cap: 967396096 (USD: 138199442.2857143)
P/E ratio: 3.984575835475578
P/B ratio: 1.3225592216521267
Debt to equity: 0.1521
Current ratio: 5.42
Interest coverage ratio: 2.5591059602649007
Return on net tangible assets (%): 5.81958581958582
Buffett classification: The Good
Rule of 40 score: 28.30387200266256
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 1.844422700587084, earnings yield % 0.4235131585968548, rank 5450
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 4.204963995869442
Total shareholder yield (%): 4.204963995869442 (Moderate Return)
Momentum (%): 1m 10.309278350515465, 3m 5.8054657506567, 6m -27.335097861670278, 12m -62.14258671666547, composite -29.07009827848911 (Strong Downtrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 4, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.385128784049149 (Likely Safe)
Equity multiplier (leverage): 1.227729541922146
ROE archetype: Standard Business
P/E z-score: 2.8523038010572135
Treasury beta 1y: 0.03427421689239127 (R-squared: 0.0003720629683391585)
Insider 90-day net shares: -8212000 (net value USD: -10039131.00)
ROIC (%): 3.007307313847515 (pretax: 3.05044472906754)
Incremental ROIC 3y (%): -10.22827515301844 (pretax: -10.260035958431358)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 33.2089552238806, P/B 31.343283582089555, ROIC 47.38805970149254, revenue growth 1y , 6m momentum 61.940298507462686
Sector percentiles: P/E 31.000813669650125, 6m momentum 64.68673718470302
Industry median P/E: 0.20627847567967422; industry median ROIC: 5.9821146700167755
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.05
Base cash flow: 7342571.428571428
DCF price per share: base 0.38584127025652537, conservative 0.19799353961866448, aggressive 0.8003611843599143
Financial scorecard for 2552.HK (Healthcare — Drug Manufacturers - Specialty & Generic, China)
Report date: 2025-12-31 (annual)
Stock price: 0.32142857142857145
Market cap: 2511229440 (USD: 358747062.85714287)
P/E ratio: 0.3096977916320871
P/B ratio: 2.726040035557999
Debt to equity: 0.29969999999999997
Current ratio: 6.17
Interest coverage ratio: -16.68966363859563
Return on net tangible assets (%): 114.98286348519713
Buffett classification: The Gruesome
Analyst consensus upside (%): 1481.424836601307
Rule of 40 score: 86.306857640989
Altman Z-score: -0.8360814810705542 (Distress Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -1.4752780398059375
Total shareholder yield (%): -1.4752780398059375 (Minimal or Negative)
Momentum (%): 1m 19.431279620853097, 3m -26.837624584717602, 6m -18.334108887854807, 12m -34.11973144349123, composite -30.00336001278426 (Strong Downtrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue growth 1y (%): 100.88933724272069
Revenue CAGR 3y (%): 203.1126031253949
Revenue deceleration: yes
Revenue growth consistency score: 112.82439053000981
Accrual ratio: 0.7947821742885989
FCF conversion rate: -0.05395746203969258
Beneish M-score: -1.4698321159588355 (Strong Manipulation Signal)
ROE (%): 252.43233821779302
Net margin (%): 224.44242028344567
Asset turnover: 0.335985156970913
Equity multiplier (leverage): 3.3474951393180348
ROE archetype: Leverage-Driven Returns
P/E z-score: 1.702066971136448
Treasury beta 1y: 0.07365630309087337 (R-squared: 0.001629226692355588)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -62.988908347927605 (pretax: -62.988908347927605)
Incremental ROIC 3y (%): 16.75062418722764 (pretax: 32.156060584262164)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 18.181818181818183, P/B 53.3724340175953, ROIC 82.99120234604106, revenue growth 1y 1.7595307917888565, 6m momentum 58.94428152492669
Sector percentiles: P/E 8.345272206303726, 6m momentum 48.42406876790831
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.08982193653053429
Base cash flow: 161610714.28571427
DCF price per share: base 1.0470317165497929, conservative 0.5963617795754388, aggressive 1.860548309740522
Financial scorecard for 2561.HK (Healthcare — Drug Manufacturers - Specialty & Generic, China)
Report date: 2025-12-31 (annual)
Stock price: 2.4362244897959187
Market cap: 2172689152 (USD: 310384164.5714286)
P/B ratio: 4.405252319325346
Debt to equity: 0.2323
Current ratio: 4.47
Interest coverage ratio: -219.07468123861568
Return on net tangible assets (%): -33.081598191817186
Buffett classification: The Gruesome
Analyst consensus upside (%): 1121.5548780487807
Rule of 40 score: -319102.42424242425
Altman Z-score: 3.467557585992651 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -8.041917218248193
Total shareholder yield (%): -8.041917218248193 (Minimal or Negative)
Momentum (%): 1m -1.3429752066115528, 3m -22.519749166929152, 6m -49.62208106996774, 12m -59.90699739015103, composite -43.83435300171126 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 4, short score 8, recommendation: Short
Revenue deceleration: no
Beneish M-score: -3.8124292497903727 (Likely Safe)
ROE (%): -51.02044159565375
Net margin (%): -153589.09090909088
Asset turnover: 0.00026210340254498814
Equity multiplier (leverage): 1.267392651037811
ROE archetype: Low Return
Treasury beta 1y: -0.10360647884050693 (R-squared: 0.004607935006719857)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -62.02116875275383 (pretax: -78.50780854778966)
Incremental ROIC 3y (%): 34.53271919879559 (pretax: 43.71230278328556)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 65.39589442815249, ROIC 82.69794721407625, revenue growth 1y , 6m momentum 85.63049853372434
Sector percentiles: P/E , 6m momentum 70.23638968481374
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10078420217534281
Base cash flow: -35963714.28571428
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 3896.HK (Technology — Software - Application, China)
Report date: 2026-03-31 (quarterly)
Stock price: 0.6403061224489796
Market cap: 22542536704 (USD: 3262306324.7467437)
P/B ratio: 3.034930767968162
Debt to equity: 1.2004000000000001
Current ratio: 1.03
Interest coverage ratio: -1.0814674956867085
Return on net tangible assets (%): -8.796770593213855
Buffett classification: The Gruesome
Analyst consensus upside (%): 1185.0782608695652
Rule of 40 score: 18.93703064345338
Altman Z-score: 0.015737635439037445 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 13.99652363251114
Total shareholder yield (%): 13.99652363251114 (High Return)
Momentum (%): 1m 3.2921810699588336, 3m -41.6344943099475, 6m -22.68749605105201, 12m -39.22124472521778, composite -35.16013552302629 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 12, recommendation: Short
Revenue growth 1y (%): 44.19860494128886
Revenue deceleration: no
Accrual ratio: -0.03200836909431073
FCF conversion rate: -1.5535261259164435
Beneish M-score: -2.543862835777344 (Likely Safe)
ROE (%): -3.7788842601472696
Net margin (%): -12.71279845783532
Asset turnover: 0.09860117237147507
Equity multiplier (leverage): 3.0146739612595925
ROE archetype: Low Return
Treasury beta 1y: 0.2235729448986113 (R-squared: 0.011142777583384118)
Insider 90-day net shares: -300000 (net value USD: -191460.00)
ROIC (%): -3.0679923989288396 (pretax: -3.8835346821884045)
Incremental ROIC 3y (%): 18.590554982770236 (pretax: 23.532348079455996)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 42.18328840970351, ROIC 51.886792452830186, revenue growth 1y 6.334231805929918, 6m momentum 54.851752021563335
Sector percentiles: P/E , 6m momentum 57.45745745745746
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.14905115948894654
Base cash flow: -440422571.4285714
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 6609.HK (Healthcare — Medical Devices, China)
Report date: 2025-12-31 (annual)
Stock price: 6.122448979591836
Market cap: 1840392448 (USD: 262913206.85714287)
P/E ratio: 2.6488230253541003
P/B ratio: 1.255698754094068
Debt to equity: 0.0377
Current ratio: 11.49
Interest coverage ratio: 37.7356935014549
Return on net tangible assets (%): 9.159943959636289
Buffett classification: The Great
Rule of 40 score: 82.04687189466908
Altman Z-score: 8.349095898078328 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 7.248137221933973, earnings yield % 1.0438102622111691, rank 4552
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.11434943587357282
Total shareholder yield (%): 0.11434943587357282 (Low Return)
Momentum (%): 1m 15.942028985507237, 3m -14.699687704263203, 6m -16.65776258147238, 12m -4.640427599611283, composite -16.369939696800103 (Strong Downtrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 8, short score 0, recommendation: Long
Revenue growth 1y (%): 53.215366528332744
Revenue CAGR 3y (%): 30.4115992941715
Revenue deceleration: no
Revenue growth consistency score: 19.352258219242124
Beneish M-score: -2.5215363455249027 (Likely Safe)
ROE (%): 7.748687303623665
Net margin (%): 20.410937431114466
Asset turnover: 0.3334498333468416
Equity multiplier (leverage): 1.1385043106539545
ROE archetype: Standard Business
P/E z-score: 1.8586503041642795
FCF z-score: 1.8586503041642792
Treasury beta 1y: 0.0063083074692393834 (R-squared: 1.3813496501622935e-05)
Insider 90-day net shares: -116000 (net value USD: -719216.00)
ROIC (%): 19.311755111146 (pretax: 20.023881150103843)
Incremental ROIC 3y (%): 548.3513162890321 (pretax: 651.7561924334499)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 10.979228486646884, P/B 19.584569732937684, ROIC 5.341246290801187, revenue growth 1y 8.011869436201781, 6m momentum 42.13649851632047
Sector percentiles: P/E 16.01002865329513, 6m momentum 46.48997134670487
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.08033797962951249
Base cash flow: 14290428.571428573
DCF price per share: base 2.956235505042669, conservative 1.7973846332188859, aggressive 5.096789378830677
Financial scorecard for 6618.HK (Healthcare — Pharmaceutical Retailers, China)
Report date: 2025-12-31 (annual)
Stock price: 4.719387755102041
Market cap: 118012649472 (USD: 16858949924.571428)
P/E ratio: 3.6615911937248695
P/B ratio: 2.6536796641325346
Debt to equity: 0.0106
Current ratio: 2.72
Interest coverage ratio: 355.08938547486036
Return on net tangible assets (%): 9.467693300598
Buffett classification: The Great
Analyst consensus upside (%): 883.3191719171916
Rule of 40 score: 44.53013144921715
Altman Z-score: 4.737826895283922 (Safe Zone)
Piotroski F-score: 1 (Weak)
Magic formula: return on capital % 10.697654898721998, earnings yield % 0.8082638400026867, rank 4059
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.3289841319112783
Total shareholder yield (%): -0.3289841319112783 (Minimal or Negative)
Momentum (%): 1m 10.778443113772466, 3m -19.73760616322985, 6m -42.30215597210671, 12m -23.45621099679542, composite -30.98115897567946 (Strong Downtrend)
Lynch category:  (confidence: Medium)
Screener: long score 9, short score 0, recommendation: Long
Revenue growth 1y (%): 31.686960122906726
Net income growth 1y (%): 34.69460892815781
Revenue CAGR 3y (%): 16.03791301100572
Net income CAGR 3y (%): 140.70660539227603
FCF CAGR 3y (%): 39.99495694061706
Revenue deceleration: no
Revenue growth consistency score: 13.488038890395794
Accrual ratio: -0.06199503742423422
FCF conversion rate: 1.8645925283769316
Beneish M-score: -2.6545504252824212 (Likely Safe)
ROE (%): 9.510298413054425
Net margin (%): 7.319303052782687
Asset turnover: 0.9796607739492894
Equity multiplier (leverage): 1.3263211528198242
ROE archetype: Standard Business
P/E z-score: 4.7279905700207205
FCF z-score: 4.727990570020723
Treasury beta 1y: -0.09284741306581756 (R-squared: 0.0045254946757739885)
Insider 90-day net shares: -5842 (net value USD: -35905.00)
ROIC (%): 27.929317521763874 (pretax: 31.378838218051573)
Incremental ROIC 3y (%): 23.18306498917763 (pretax: 26.1297729254718)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 48, P/B 48, ROIC 0, revenue growth 1y 4, 6m momentum 68
Sector percentiles: P/E 16.869627507163322, 6m momentum 66.65472779369628
Industry median P/E: 0.15154711900058024; industry median ROIC: 5.985153957145241
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.11007720756793668
Base cash flow: 786340714.2857143
DCF price per share: base 1.8075674911727888, conservative 1.2303369273768552, aggressive 2.8132952626652146
Financial scorecard for 6628.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 0.14413265306122447
Market cap: 481601728 (USD: 68800246.85714285)
P/B ratio: 1.3152553636188982
Debt to equity: 0.2043
Current ratio: 0.26
Interest coverage ratio: -28.237309057244254
Return on net tangible assets (%): -321.31222167243936
Buffett classification: The Gruesome
Rule of 40 score: -2065.2415483008176
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 16.381705633302403
Total shareholder yield (%): 16.381705633302403 (High Return)
Momentum (%): 1m -3.4188034188034226, 3m -53.17183927512915, 6m -48.66508247134471, 12m -59.59138119533528, composite -53.332636451934434 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.05853404133599354
FCF conversion rate: 0.7017940851638238
Beneish M-score: -2.319850244893578 (Likely Safe)
Equity multiplier (leverage): 1.5452340287867188
ROE archetype: Standard Business
Treasury beta 1y: 0.1548972353546398 (R-squared: 0.0023050981091877177)
Insider 90-day net shares: 30000 (net value USD: 8205.00)
ROIC (%): -19.798954826941145 (pretax: -25.061968135368534)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 15.162454873646208, ROIC 14.981949458483754, revenue growth 1y , 6m momentum 65.34296028880865
Sector percentiles: P/E , 6m momentum 69.52005730659026
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -23191857.14285714
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 6908.HK (Technology — Semiconductors, Hong Kong)
Report date: 2025-12-31 (annual)
Stock price: 0.047193877551020405
Market cap: 428388448 (USD: 55062782.5192802)
P/B ratio: 1.0695889960991443
Debt to equity: 0.032799999999999996
Current ratio: 4.7
Interest coverage ratio: -116.10027347310849
Return on net tangible assets (%): -27.60482171732846
Buffett classification: The Gruesome
Rule of 40 score: -79.86616888784121
Altman Z-score: 2.814628856437553 (Grey Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.3414961218342031
Total shareholder yield (%): 0.3414961218342031 (Low Return)
Momentum (%): 1m -11.904761904761905, 3m -24.586109954185755, 6m -26.37755102040818, 12m -32.64146567717998, composite -24.834207337851666 (Strong Downtrend)
Lynch category: Asset Play (confidence: Low)
Screener: long score 3, short score 13, recommendation: Short
Revenue growth 1y (%): 29.523247943345687
Revenue CAGR 3y (%): 3.802004992714436
Revenue deceleration: no
Revenue growth consistency score: 22.325552739665277
Accrual ratio: -0.06570685650306732
FCF conversion rate: 0.6538904439641428
Beneish M-score: -2.6660691027605146 (Likely Safe)
ROE (%): -20.82803011719327
Net margin (%): -115.47990466350923
Asset turnover: 0.16439578698547228
Equity multiplier (leverage): 1.0971123320481337
ROE archetype: Low Return
Treasury beta 1y: -0.0579743871216002 (R-squared: 0.0014364132916766228)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -21.261359073946508 (pretax: -26.913112751831026)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 19.753086419753085, ROIC 74.69135802469135, revenue growth 1y 24.691358024691358, 6m momentum 77.77777777777779
Sector percentiles: P/E , 6m momentum 61.39472806139473
Industry median P/E: 31.956834532374103; industry median ROIC: 3.679818125534067
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.05
Base cash flow: -17378406.16966581
DCF price per share: base 0, conservative 0, aggressive 0